COMPOUNDED TIRZEPATIDE

Regular price: $339
Regular price: $0
Sale price: $339

START NOW

Pricing is for a monthly supply. Prescription medication. Medical evaluation required.

What is compounded tirzepatide?

Compounded tirzepatide is a dual-action GLP-1 and GIP therapy, compounded by a state-licensed pharmacy and prescribed through provider-led telehealth. Sometimes searched as "compound tirzepatide" or "tirzepatide compound," it is the same medication prepared for an individual patient by prescription. At Fitish RX it is built for women and priced flat at $339 for a monthly supply, with your provider consult and shipping included.

Tirzepatide is a dual action GLP-1 and GIP receptor agonist. It is the only medication of its kind currently used to support weight management. Most weight management medications target a single hormone pathway. Tirzepatide activates two: GLP-1, which slows digestion and helps regulate appetite, and GIP, which influences how your body responds to insulin and stores energy.

Together, these two pathways are why patients on tirzepatide often experience steadier appetite control, more consistent progress, and improved metabolic markers compared to single hormone therapies. Once weekly subcutaneous injection. Doses are gradually titrated by your provider to support tolerance.

Benefits patients commonly report

Reduced appetite and food noise
Steadier, more sustainable weight management when paired with diet and lifestyle changes
Improved insulin sensitivity and blood sugar regulation
More predictable daytime energy
Less reactive eating and fewer cravings

A note on whole body wellness

Many patients describe broader lifestyle wins as their habits steady, including better sleep, more consistent meals, and a clearer sense of routine.

What to expect

Most patients begin to feel changes in appetite within the first 1 to 2 weeks. Visible changes in weight typically follow over 8 to 16 weeks of consistent use, supported by hydration, protein intake, and movement habits guided by your provider. When side effects occur, they are usually mild to moderate gastrointestinal symptoms (nausea, constipation, indigestion) and tend to ease as your body adjusts.

Who it's for

Adults pursuing medical weight management whose BMI and medical history meet clinical eligibility criteria. A licensed Fitish provider reviews every intake before any prescription is issued.

How Fitish RX works

Getting started takes minutes. You complete a short online intake about your health and goals. A licensed provider reviews it, and if tirzepatide is a fit, writes your prescription. Your medication ships discreetly from a licensed compounding pharmacy on a monthly cadence. From there, your care team stays with you through the patient portal for dose adjustments, questions, and ongoing support at no added cost.

Important to know

Compounded tirzepatide is prepared by a state licensed sterile compounding pharmacy. Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. FDA-approved tirzepatide products (Mounjaro®, Zepbound®) are commercially available. Your provider may recommend compounded tirzepatide where clinically appropriate based on your evaluation.

Full dose or microdose

Fitish RX offers two distinct GLP-1 lanes so you can match the program to your goal:

Compounded tirzepatide (full dose), $339 / monthly supply. For patients pursuing serious, sustained weight management who meet clinical criteria.
Microdose tirzepatide, $269 / monthly supply. A lower, fixed dose for those who want a gentle, mindful, cosmetic approach rather than full dose weight loss. It does not titrate up.

Both are provider led and ship monthly. If you are not sure which lane fits, complete your intake and your provider will recommend the right one.

These statements have not been evaluated by the Food and Drug Administration. Individual results vary. This product is not intended to diagnose, treat, cure, or prevent any disease.

Not a fit for compounded GLP-1? You may still qualify for our Microdosing program, a lower dose option designed for patients outside the standard BMI range. Eligibility for our compounded GLP-1 program is based on BMI and clinical criteria reviewed by a licensed provider. If your BMI falls below the threshold for compounded GLP-1, you may still be a candidate for our Microdosing program, a lower dose protocol built for patients seeking the metabolic, appetite, and longevity benefits of GLP-1 therapy at a gentler entry point. A provider will review your intake and recommend the program that fits your goals and health profile.

Learn more about Microdosing

Want the gentle lane explained? Read our guide to microdosing tirzepatide, or compare starting doses side by side in the GLP-1 microdosing dose chart.

Frequently asked questions

What is compounded tirzepatide?

Compounded tirzepatide is tirzepatide prepared by a state licensed sterile compounding pharmacy and dispensed by prescription. Compounded medications are not FDA-approved. It is used for medically supervised weight management when a licensed provider determines it is appropriate.

Is "compound tirzepatide" the same as compounded tirzepatide?

Yes. "Compound tirzepatide" and "tirzepatide compound" are common ways people search for compounded tirzepatide, the version prepared by a state licensed compounding pharmacy by prescription. Compounded medications are not FDA-approved. A licensed provider determines whether it is appropriate for you.

Where can I get compounded tirzepatide for women?

Through Fitish RX. Complete a short online intake, a licensed provider reviews it, and if compounded tirzepatide is appropriate your prescription ships monthly from a licensed pharmacy. Pricing is flat at $339 for a monthly supply, with the consult and shipping included.

How much does compounded tirzepatide cost at Fitish?

$339 for a monthly supply. That price includes your provider consult, the medication if you are approved, and shipping. There are no separate consult or membership fees.

Do I need insurance?

No. Fitish RX is direct-pay telehealth with transparent, all-in pricing. You do not need to involve insurance.

Can I pay with my HSA or FSA?

Sometimes. Some plans and cards will go through and others will not, and that part is largely outside our control. Card networks currently treat compounded telehealth prescriptions inconsistently, so an HSA or FSA card can be declined at checkout even when your plan would otherwise allow the expense. Eligibility is determined by your plan and your plan administrator, not by us. If you want to use those funds, the most reliable route is to check with your administrator first, pay with any other card, and submit for reimbursement. Your provider can issue a Letter of Medical Necessity to support that request.

How is it taken?

Tirzepatide is a once weekly subcutaneous injection. Your provider sets your starting dose and a gradual step-up plan, personalized to you and documented in your patient portal.

What are the most common side effects?

The most commonly reported side effects are mild to moderate gastrointestinal symptoms such as nausea, constipation, and indigestion, and they usually ease as your body adjusts. Starting at a low dose and increasing slowly helps. Your provider reviews the full safety profile with you before you begin.

What if I do not qualify for full-dose tirzepatide?

You may still be a candidate for the Fitish Microdosing program, a lower dose option for patients outside the standard BMI range who want a gentler, cosmetic approach. Your provider recommends the program that fits your health profile after reviewing your intake.

New to GLP-1? Read our guide to weight loss shots and how they work.

For more detail, see The Clinic FAQ page or our Fitish RX Safety Information. The Black Box warnings, full side effect list, and drug interaction details remain in the Safety Details section below.

More

Tirzepatide is a GLP-1 and GIP receptor agonist medication. Compounded tirzepatide is custom-prepared by a state-licensed compounding pharmacy based on a prescription from a licensed provider. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. State-licensed compounding pharmacies follow both federal and state regulations, including quality standards.

FAQ

What is Tirzepatide? Tirzepatide is a dual GLP-1 and GIP receptor agonist. It works with two hormone pathways that help regulate appetite and support metabolic balance by targeting areas of the brain involved in hunger cues.
How much weight can I lose with Tirzepatide? Everyone’s journey is different, and individual results vary based on lifestyle, consistency, dose, and personal response. Your provider can discuss what may be realistic for you. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety or effectiveness.
What are the most common side effects of Tirzepatide? The most commonly reported side effects include: nausea, constipation or diarrhea, bloating or heartburn, belching, dizziness, vomiting, and general upset stomach. These are typically mild and improve as your body adjusts, though experiences may vary.
What is Compounded Tirzepatide? Compounded tirzepatide is a custom-formulated preparation of tirzepatide made by a state-licensed compounding pharmacy to meet individual patient needs. Tirzepatide acts on GLP-1 and GIP pathways that influence insulin response, digestion, and appetite. Compounded medications are not FDA-approved.
What are the benefits of Compounded Tirzepatide? More affordable: brand-name options can be expensive and are often not covered by insurance for weight loss, so compounded versions tend to cost less. Easier to access: compounding can help when commercial supply is limited. Personalized: compounding allows for flexible dosing options tailored by your provider. Compounded medications are not FDA-approved.

Safety Details

Compounded Tirzepatide (Injection)
BLACK BOX WARNING: RISK OF THYROID C-CELL TUMORS

Tirzepatide may cause serious side effects, including possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Tirzepatide and medicines that work like Tirzepatide caused thyroid tumors, including thyroid cancer. It is not known if Tirzepatide will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

ABOUT COMPOUNDED MEDICATIONS

Compounded tirzepatide is prepared by a state licensed sterile compounding pharmacy and is prescribed where clinically appropriate based on your medical evaluation. Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. Your provider determines your dose based on your medical evaluation. FDA-approved medicines containing tirzepatide are commercially available.

Do not use Tirzepatide if:

You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).

You have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Tirzepatide may cause serious side effects, including:

Inflammation of the pancreas (pancreatitis): Stop using Tirzepatide and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.

Low blood sugar (hypoglycemia): Your risk for getting low blood sugar may be higher if you use Tirzepatide with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.

Serious allergic reactions: Stop using Tirzepatide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.

Kidney problems (kidney failure): In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.

Severe stomach problems: Stomach problems, sometimes severe, have been reported in people who use Tirzepatide. Tell your healthcare provider if you have stomach problems that are severe or will not go away.

Changes in vision: Tell your healthcare provider if you have changes in vision during treatment with Tirzepatide.

Gallbladder problems: Gallbladder problems have happened in some people who use Tirzepatide. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.

SIDE EFFECTS
Many people experience no side effects. Some of the most common or potential side effects of Tirzepatide include:

Nausea

Diarrhea

Decreased Appetite

Vomiting

Constipation

Indigestion

Stomach (Abdominal) Pain

These are not all the possible side effects of Tirzepatide. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.

DRUG INTERACTIONS
As with other medications, compounded Tirzepatide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Tirzepatide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Tirzepatide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (i.e., warfarin) should be monitored closely while on Tirzepatide.

This summary provides basic information about compounded Tirzepatide but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about compounded Tirzepatide and how to take it. Your healthcare provider is the best person to help you decide if compounded Tirzepatide is right for you.

Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions, and additional information.

You are encouraged to report negative side effects of compounded tirzepatide to the FDA. Visit https://www.fda.gov/medwatch or call 1800FDA1088. In case of emergencies, please call 911 or go to the nearest emergency room.